Chemical Structure : Palivizumab
CAS No.: 188039-54-5
货号: PC-Ab1100Not For Human Use, Lab Use Only.
Palivizumab (MEDI-493) is a monoclonal antibody to the RSV F protein that inhibits binding of the virus to cellular receptors. This reduces viral activity and cell-to-cell transmission, and blocks the fusion of infected cells. Palivizumab is directed at an epitope in the A antigenic site of the 'F' protein on the surface of RSV. Palivizumab binds to this epitope, which is highly conserved among different RSV isolates..
| 规格 | 价格 | 库存 | 数量 | 
|---|---|---|---|
| 1 mg | ¥3580 | In stock | |
| 5 mg | ¥7580 | In stock | |
| 10 mg | ¥12800 | In stock | |
| 100 mg | Get quote | 
大包装,大折扣!
E-mail: sales@probechem.com
Tech Support: tech@probechem.com
Palivizumab (MEDI-493) is a monoclonal antibody to the RSV F protein that inhibits binding of the virus to cellular receptors. This reduces viral activity and cell-to-cell transmission, and blocks the fusion of infected cells. Palivizumab is directed at an epitope in the A antigenic site of the 'F' protein on the surface of RSV. Palivizumab binds to this epitope, which is highly conserved among different RSV isolates.
| 分子量 | ||
| 分子式 | Human IgG1-Kappa | |
| 外观性状 | Solid | |
| 储存条件 | 
                            
  | 
                        
                            
  | 
                    
| Solubility | 
                             PBS, pH 7.0 Contains no stabilizers or preservatives  | 
                    |
| Chemical Name/SMILES | 
                             Palivizumab; Synagis; MEDI-493; 188039-54-5; Anti-RSV fusion protein; Anti-RSV fusion glycoprotein; Anti respiratory syncytial virus fusion protein; Anti-RSV fusion  | 
                    |
1. 1, Johnson S, et al. J Infect Dis. 1997 Nov;176(5):1215-24. 2, Malley R, et al. J Infect Dis. 1998 Dec;178(6):1555-61. 3, Johnson S, et al. J Infect Dis. 1999 Jul;180(1):35-40. 4, Russell AB. Hosp Med. 1999 Dec;60(12):873-7.
备案号:沪ICP备16042516号-1 Copyright © 2022 probechem.com. All Rights Reserved. probechem Copyright